Edwards Lifesciences Corporation

EW.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EW.SW stands at 0. In comparison, EI.SW has a market cap of 88.1B. Regarding current trading prices, EW.SW is priced at CHF 188.26, while EI.SW trades at CHF 117.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EW.SW currently has a P/E ratio of N/A, whereas EI.SW's P/E ratio is 35.06. In terms of profitability, EW.SW's ROE is +0.10%, compared to EI.SW's ROE of +0.06%. Regarding short-term risk, EW.SW and EI.SW have similar daily volatility (0.00).Check EI.SW's competition here

EW.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EW.SW stands at 0. In comparison, FRE.SW has a market cap of 15.7B. Regarding current trading prices, EW.SW is priced at CHF 188.26, while FRE.SW trades at CHF 53.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EW.SW currently has a P/E ratio of N/A, whereas FRE.SW's P/E ratio is 16.21. In terms of profitability, EW.SW's ROE is +0.10%, compared to FRE.SW's ROE of +0.04%. Regarding short-term risk, Volatility data is not available for a full comparison. EW.SW has daily volatility of 0.00 and FRE.SW has daily volatility of N/A.Check FRE.SW's competition here